{"id":"W2214942476","doi":"10.1634/theoncologist.2015-0295","title":"S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors","year":2015,"lang":"en","type":"article","venue":"The Oncologist","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Bevacizumab; Imatinib; Oncology; Internal medicine; Stromal cell; Phases of clinical research; Imatinib mesylate; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001288996,0.0004094386,0.001687283,0.0002194513,0.00009869636,0.00003759582,0.0002619058,0.00001749982,0.0001600979],"category_scores_gemma":[0.001725881,0.000158795,0.00006855257,0.0007313318,0.0007438746,0.0001113946,0.0001037082,0.0003921215,0.0000124497],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003929327,"about_ca_system_score_gemma":0.001243698,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003703186,"about_ca_topic_score_gemma":0.003811309,"domain_scores_codex":[0.9963657,0.000771908,0.0007491655,0.0004231156,0.001010752,0.0006793352],"domain_scores_gemma":[0.9971964,0.0008180296,0.0004689838,0.0005402978,0.0005738849,0.0004024523],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7139068,0.01238512,0.2693837,0.0000576786,0.0003013021,0.002773678,0.0007154937,0.0001270211,0.00001868989,0.00000802652,0.00005003628,0.0002724228],"study_design_scores_gemma":[0.7911855,0.1681892,0.02757772,0.0007591417,0.000817196,0.001599943,0.008184319,0.001390544,0.00009561577,0.00001692223,0.000003027195,0.0001808792],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922507,0.00001422888,0.0001760942,0.0001448948,0.00001109405,0.006490689,0.00003039281,0.00006146973,0.0008203773],"genre_scores_gemma":[0.9899777,7.426674e-7,0.008537951,0.00002350511,0.00001837563,0.000537442,0.00005837248,0.0000424381,0.0008035181],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.241806,"threshold_uncertainty_score":0.6475474,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06706704764157113,"score_gpt":0.3680813062434201,"score_spread":0.3010142586018489,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}